Company record
Granules Pharmaceuticals Inc.
0 FDA warning letters since 2023 and 1 recall in the last 12 months.
Get an email the day FDA posts anything new about Granules Pharmaceuticals Inc..
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Feb 11 | Class II | Granules Pharmaceuticals Inc. Drug |
Trazodone Hydrochloride, USP, 50 mg, 100-Count Bottle, Rx only, Manufactured by: Granules India Limited, Hyderabad, 500 081, India, Manufactured for: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-231-01. Presence of Foreign Tablets/Capsules FDA notice D-0305-2026 |